Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

First robotic telesurgery applied to bariatric surgery in Latin America: technical fundamentals, operational challenges and perspectives in clinical practice.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery·2026

Same author

Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma.

Neuromolecular medicine·2026

Same author

<i>DLG2</i>-<i>DLG4</i> Expression Is Associated with Improved Survival and a Synaptic Gene Signature in Lower-Grade Glioma.

Cancers·2026

Same author

Comment on Santana-Bejarano et al. NRP1 and GFAP Expression in the Medulloblastoma Microenvironment: Implications for Angiogenesis and Tumor Progression. <i>Cancers</i> 2025, <i>17,</i> 2417.

Cancers·2026

Same author

ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery·2026

Same author

Comment on Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. <i>Cancers</i> 2025, <i>17</i>, 3659.

Cancers·2026

Search research articles

Related Experiment Video

Updated: Sep 13, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

GABAergic Influences on Medulloblastoma.

Viviane Aline Buffon¹, Jurandir M Ribas Filho¹, Osvaldo Malafaia¹

¹Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Curitiba 80730-000, Brazil.

|July 29, 2025

Summary

γ-aminobutyric acid (GABA) influences medulloblastoma (MB) cell survival, particularly through GABA_A receptors with the α5 subunit. Targeting the GABAergic system shows promise for MB treatment and prognosis.

Keywords:

GABAA receptor GABAA α5 subunit GABRA5 medulloblastoma pediatric brain cancer γ-aminobutyric acid

More Related Videos

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Related Experiment Videos

Last Updated: Sep 13, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Area of Science:

Neuro-oncology
Molecular Biology
Cancer Research

Background:

Medulloblastoma (MB) is a common pediatric brain tumor originating in the cerebellum.
γ-aminobutyric acid (GABA) is a key neurotransmitter regulating neuronal development and function.
GABA signaling impacts cell proliferation and differentiation in various cancers, including brain tumors.

Purpose of the Study:

To investigate the role of the GABAergic system in medulloblastoma (MB) cell viability and prognosis.
To explore GABA_A receptor subunit expression in MB subgroups.
To assess the potential of GABAergic components as therapeutic targets and biomarkers for MB.

Main Methods:

Analysis of GABA and GABA_A receptor agonist effects on MB cell viability.
Examination of gene expression for GABA_A receptor subunits (e.g., GABRA5, GABRB1) in MB tumor samples.
Correlation of gene expression levels with patient survival data across different MB molecular subgroups.

Main Results:

GABA and GABA_A receptor agonists reduce MB cell viability, acting via α5 subunit-containing receptors.
High expression of GABRA5 is linked to poorer survival in Group 3 and Group 4 MB.
Elevated GABRB1 expression correlates with improved survival across all MB subgroups.

Conclusions:

The GABAergic system, particularly GABA_A receptors, plays a significant role in medulloblastoma progression.
GABRA5 and GABRB1 expression levels may serve as prognostic biomarkers for MB patients.
Targeting the GABAergic system presents a potential therapeutic strategy for medulloblastoma.